Chris Aylward

Chris Aylward is an experienced professional in mergers and acquisitions, particularly within the healthcare sector, holding significant positions across various organizations. Currently serving as a Non Executive Advisor at Tribute Funerals since November 2023, Aylward provides expert guidance on M&A activities. Previously, Aylward was the Chief Investment Officer at Riverdale Healthcare, leading efforts in clinically led dental services from December 2018 to November 2023. Aylward has a proven track record in business development, having delivered over 100 acquisitions as Head of Mergers and Acquisitions at Oasis Dental Care. Aylward's extensive background also includes roles at Funeral Partners Limited, PharmaTrust UK, Boots UK, and Alliance Pharmacy, emphasizing leadership in acquisition strategies, operational management, and market expansion. Educational credentials include a B.Pharm from The School of Pharmacy, University of London, and Executive education at INSEAD.